Zrinka Ivezić Schönfeld, PhD

Consultant to CEO and Head of Clinical Development

Zrinka is a senior executive with nearly 30 years’ experience in the biotech & pharma industry, with an educational background in medicinal and organic chemistry. Zrinka has led multidisciplinary, international drug discovery and development projects. She has built teams and departments, from the early research and pre-clinical stages, all the way through the multiple phases of clinical trials, as well as post-marketing studies of drugs and medical devices. She has held positions as Partner & Managing Director at SILSC GmbH (Austria); Corporate Director Clinical Development at Croma-Pharma GmbH (Austria); Managing Director/VP of Non-Clinical Development and Head of Clinical Sciences Pharmacology & Toxicology at Nabriva AG (Austria, USA); and Program Director for anti-infective drug research at PLIVA Research Institute (Croatia).

At Origimm, Zrinka is primarily responsible for clinical development. Joining at the beginning of 2020, she set up clinical department organization and led the team through an intense phase of preparation for the first clinical trial to investigate a therapeutic acne vaccine. Being very thorough and structured in her work, she was responsible for connecting all the dots in this highly cross-functional project. Within the management team, Zrinka also contributes to business strategy, including market research and interactions with key opinion leaders (KOLs). With her broad experience in leadership and strategy, Zrinka contributes significantly to the development of the company.